Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment

New data show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100 percent rate of sustained virological response -- undetectable HCV RNA -- 12 weeks after treatment (SVR12).

Read the whole article on Science Daily

More from Science Daily